NY I-STOP Deadline Approaching

Posted by on Comments (0)

The New York State Internet System for Tracking Over-Prescribing (I-STOP) Act mandates that all prescriptions, both controlled and non-controlled, be sent electronically. Last year the deadline for prescribers to meet the regulation was postponed until March 27, 2016. This new deadline is fast approaching.

In order to comply with I-STOP, prescribers must select and use a certified electronic prescribing computer application that meets all federal requirements for electronic prescriptions for controlled substances (EPCS).  This includes going through Identity Proofing and setting up 2-Factor authentication. The practitioner must also register each unique certified computer application used to electronically prescribe controlled substances with the New York State Department of Health (DOH), Bureau of Narcotic Enforcement (BNE).

The BNE recently sent out a letter to all prescribers advising the following:

“Please be aware that implementation timelines for EPCS software vary and may be lengthy. If you have not already begun this process, BNE strongly recommends that you begin immediately. Prescribers who have certified EPCS software and have completed the registration process are highly encouraged to begin electronically prescribing instead of using paper, to allow for time to resolve technical or workflow issues prior to the mandate’s effective date.”

MDToolbox has a simple signup process for both standard e-Prescribing and to setup EPCS. Most prescribers can complete the required ID proofing and 2-Factor Authentication setup within one day, but we also urge prescribers in NY to get started as soon as possible. This will ensure time to complete the application process and get all staff setup and trained.

To sign up for a free 30 day e-Prescribing trial with EPCS: New York e-Prescribing Account

Once you have signed up, you can register the application at:          

http://www.health.ny.gov/professionals/narcotic/electronic_prescribing/ropes.htm

E-Prescribing of Controlled Substances Available in All 50 States

Posted by on Comments (0)

Electronic Prescribing of Controlled Substances (EPCS) is now legal in all 50 States.  Missouri and Vermont were the last two states to authorize electronic prescribing of controlled substances.  Missouri’s regulations became effective July 30th, 2015.  Today, August 28th, Vermont became the final state to allow prescribers to legally prescribe controlled substances electronically for schedule II-V drugs.  Prescribers can now electronically prescribe controlled substances at any participating pharmacy in the United States. 

National EPCS availability is a key step in combating prescription drug fraud and abuse.  With the adoption of EPCS, patients will no longer be able to forge paper prescriptions.  Drug seeking behaviors and patterns will also be easier to identify and respond to.  With the increased electronic connectivity of pharmacies, medication histories will be more readily available.  All of these factors will also create a much safer environment for patients. 

The state of New York has passed legislation requiring prescribers to do all of their prescribing electronically starting in March next year.  As that deadline draws near and potentially other states follow, it will be necessary to stay current and have a viable EPCS solution.  Currently, the national average of pharmacies enabled for EPCS is 80.3%. Now that EPCS is legal in all states and as more states make EPCS a requirement, we expect to see more and more pharmacies coming online and allowing receipt of EPCS. 

MDToolbox offers both a certified stand-alone e-Prescribing solution, as well as an integratable solution for EHR or PM systems to add full e-Prescribing capabilities or add on just EPCS capabilities. MDToolbox is ready to help prescribers and software companies through the DEA requirements to get fully prescribing controlled and non-controlled substances electronically. Check out our EPCS page or contact us at info@mdtoolbox.com for more info.  

Less than 2% of Prescribers Utilizing EPCS

Posted by on Comments (0)

Surescripts recently released its 2014 National Progress Report and one of the most startling findings is that only 1.4% of providers are enabled for Electronic Prescribing of Controlled Substances (EPCS).1

A much larger percent of pharmacies are setup to utilize EPCS. The national average of pharmacies enabled for EPCS is 74.9%.  A state by state comparison of the percent of pharmacies with EPCS capability, can be found on our EPCS page.

Even though EPCS is now legal in 49 states and D.C., its growth has been rather slow compared to the rates of non-controlled e-Prescribing. Surescripts’ report also found that 67%, or 1.2 billion, of all new prescriptions in 2014 were e-Prescribed. However, while there was a 400% increase in controlled substance e-Prescribing from 2013 to 2014, the number of controlled substance prescriptions was only 1.67 million.

 

Out of almost 70,000 total pharmacies and more than half a million e-Prescribing prescribers, the amount of pharmacies utilizing EPCS far surpasses the amount of prescribers.

 

While the statistics are surprising considering EPCS has been legal since 2010, there are several factors involved in the low percentage of prescribers. These include issues such as their software not being ready to meet the DEA requirements, as well as the number of steps that prescribers must go through to be setup for EPCS.

Though the steps involved may seem complex, e-Prescribing vendors are doing their best to make the process as smooth as possible for prescribers to utilize this important technology. MDToolbox has created a simple 4-step process that walks prescribers through completing the DEA requirements for EPCS that can be completed within minutes.* We also provide this EPCS solution as an integration option so that EHRs and other technology vendors can add the streamlined process to their existing workflow.

There are several benefits of EPCS including increasing patient safety and security, as well as reducing fraud and abuse. The easier it is for prescribers to setup and use EPCS, the more likely they will be to take advantage of the benefits and increase their usage.

Click here for more on EPCS for prescribers

Click here for more on EPCS for technology vendors

*Time varies based on token selection and results of identity verification

1.  2014 National Progress Report http://surescripts.com/news-center/national-progress-report-2014#public

New York Delays e-Prescribing Mandate One Year

Posted by on Comments (0)

New York State has officially delayed the requirement to send all prescriptions electronically one year until March 27, 2016. The delay came just two weeks before the original I-STOP mandate was set to go into effect. Under I-STOP, providers will be required to send both non-controlled and controlled substances electronically. Paper prescriptions will no longer be allowed.

The main reason for the delay was stated as a lack of software vendors being ready.  While most software has the ability to electronically send non-controlled prescriptions, some are still lacking the ability to electronically prescribe controlled substances (EPCS). EPCS capability requires completing an audit by a DEA-approved auditor to prove that certain security measures are in place. 

The advantages of e-Prescribing are plentiful from patient safety to efficiency in prescribing to combatting doctor shopping. However, many of these benefits could be lost by either using software that isn’t truly ready or rushing into trying to use software that is complex. The additional time will be beneficial for prescribers. Providers can now pick the solution that is right for them without being rushed and get their practice adjusted to e-prescribing more slowly.

The delay will also take some of the pressure off those vendors who are still trying to add EPCS capabilities. While MDToolbox was one of the first vendors to be approved by the DEA for sending controlled substances, we understand the complexities involved in becoming an approved vendor. It is not an easy process. This additional year will give EHRs and other software vendors the necessary time to implement the requirements as smoothly as possible into their workflows and ensure they do not lose their providers to other vendors. Many vendors have chosen to partner with other vendors to help them meet the requirements. This is a great way to integrate EPCS and the required features such as Identity Proofing, 2-factor authentication, and Permissions without having to exert many resources. Having all of the required features come together in a package that can seamlessly integrate takes a lot of the legwork, expenses, and stress out of the process.

Whatever path vendors and prescribers choose to take, they must seize this opportunity to guarantee they are fully ready when the new deadline comes around.

Click here for further information on adding MDToolbox EPCS to your software

Click here for further information on MDToolbox standalone e-Prescribing software

Texas Department of Public Safety Guidelines for EPCS

Posted by on Comments (0)

The recent rescheduling of hydrocodone combination products and the requirement to use special approved prescription paper for Schedule II drugs in Texas, has caused many prescribers to turn to e-Prescribing as an alternative. As prescribers look to this electronic alternative, there are several questions that come up as the Texas Department of Public Safety (Texas DPS) has given out some state specific guidelines. Here’s what prescribers need to know:

Is e-Sending Schedule II drugs allowed in Texas?

In October of 2013 the Texas DPS accepted the same requirements, with a few updates of their own, as the DEA in regards to sending Schedule II controlled substances electronically. 1

What are the Texas State Guidelines?

In order to comply with the Texas DPS guidelines, there are several things prescribers must be aware of and know before they start using an EPCS program. Prescribers must make sure that their vendor is certified by the DEA, meaning that they passed the required third party audit. Prescribers will also want to be sure that the vendor has EPCS capability activated for their state. Prescribers must also make sure that all their necessary credentials are included when e-Sending a prescription.

DPS, DEA and APN Numbers

The numbers prescribers now put down for paper prescriptions, their DPS, DEA and APN numbers for advanced practice nurses must also be on their electronic prescriptions as well. When prescribers are setting up their e-prescribing account they want to make sure that this information can be entered in the appropriate fields.

APNs will also enter their prescriptive authority identification number for all prescriptions written.  APNs and physicians assistants with prescriptive authority should also keep in mind they must include the DEA and DPS number of their supervising practitioner on all prescriptions schedules III-V.2

Control Numbers

Paper prescriptions written in the state of Texas for schedule II drugs require that each prescription be printed on DPS required paper that has a unique Control Number listed for the pharmacy to record. With e-prescribing all control number information, locating, and documenting is now handled entirely on the pharmacies end electronically.

What Does This Mean Now?

Texas DPS completed their beta testing of EPCS March 1, 2014. The purpose of which was to monitor Schedule II prescriptions for abuse, prescribing patterns, patients attempting to get prescriptions from multiple doctors, and fraudulent prescriptions. Also, to make sure all reporting on both the provider’s end and the pharmacy’s end was done accurately and in a timely manner.

After the results of the testing came back, the outcome was clear. Provider’s information was safer, as their DPS and DEA numbers were no longer floating around on written prescriptions for people to try to forge prescriptions with. The DPS information is also now easier and faster to track with everything being electronic. Patients’ information was also safer and relayed faster as there was no longer the constant need to rely on a phone or fax for patient information that may or may not have made it to the desired party on the other end.

Electronically prescribing controlled substances has proven to not only be a viable alternative to paper prescriptions in Texas, but an improvement. To get more information on EPCS or to start sending controlled substance electronically contact us at info@mdtoolbox.com or visit our EPCS page.

  1. https://www.pharmacy.texas.gov/EPCS.asp
  2. http://www.dps.texas.gov/RSD/ControlledSubstances/News/index.htm.

Hydrocodone Rescheduling Effective October 6, 2014

Posted by on Comments (0)

DEA ISSUES FINAL RULING FOR HCPs TO BE RESCHEDULED FROM CLASS III TO CLASS II

The DEA has officially ruled that all hydrocodone combination products or HCPs (ex: Vicodin and Lortab) are to be rescheduled, moving them from Schedule III to II based on the Controlled Substances Act1. The ruling was made official August 22, 2014 and will be put into effect starting October 6, 2014.

 

HOW DOES THIS EFFECT PRESRCIBING?

Starting next week, all HCPs will be schedule II controlled substances (CS). This will cause several things to change and impact providers, as well as patients alike. Providers will no longer be able to write prescriptions for HCPs with refills and they will be limited to a 3 month supply at most (the rule also mandates that doctors must write the prescriptions in 30-day increments that can only be filled sequentially). Pain patients using the drugs will have to visit their doctors every three months for a new prescription. The rule also limits which providers in certain states can write these prescriptions, as well as how they can be sent.

Due to HCPs now being a schedule II CS, only practitioners registered with the DEA will be able to prescribe the drugs. However, some states have separate laws in place that limit this even further.  For example, in the states of Alabama, Georgia, Missouri, and South Carolina nurse practitioners are not allowed to prescribe, administer, or dispense schedule II CSs.

Providers are only left with two options for prescribing these schedule II drugs:

Paper Prescriptions 

According to the DEA, prescriptions for schedule II CSs cannot be phoned in or faxed to a pharmacy with the exception of emergency situations. In the case one of the situations comes to pass, the provider that authorized the emergency oral prescription has 7 days to produce a paper prescription to the pharmacy, which can be hand delivered or mailed if post marked within the 7 day period. If a prescription is faxed, it cannot be dispensed until a physical copy of the prescription is presented and reviewed. A prescription for a schedule II CS must be written with ink, indelible pencil, typed, or generated by an electronic system on tamper-proof prescription forms and hand signed if they are to be hand delivered to the pharmacy.

Electronic Prescriptions

The second way that a provider can prescribe a schedule II drug is through e-Prescribing. EPCS, or Electronic Prescribing of Controlled Substances, offers a viable solution for prescribers to not only meet the DEA requirements for schedule II prescriptions, but increase their workflow and patient safety at the same time.   With Electronic Prescriptions, the prescriber also must sign each prescription but instead of using ink, he uses a digital signature that is generated with a two-factor sign-off credential.  When the prescription is sent electronically the pharmacist can see that the order was electronically signed and knows that it came from the prescriber and was not forged.    EPCS is approved for Prescribers in 49 states for Schedule III-V and in 47 States for Schedule II drugs, meaning in most of the U.S. prescribers can use EPCS to safely send Vicodin and other schedule II drugs.

MDToolbox has made the process easy and straightforward for providers.  When a provider first signs up for EPCS, they will go through an identity proofing process and set up their two factor credentials. Once set up is complete, writing and sending a prescription for a CS is just as easy as a non CS, the only difference being entering the two-factor signing credentials that assures it is the doctor authorizing the prescription.   To get more information on how EPCS works, or to find out about signing up for our EPCS Stand Alone or EHR Integration Add on, contact us at info@mdtoolbox.com or visit our EPCS page.

 

    1. http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0822.htm

EPCS Status Update

Posted by on Comments (0)

With only three states left to approve EPCS and a few others working on their final requirements, EPCS is gaining great traction in 2014.  As more and more pharmacies come online every day, MDToolbox is excited to be at the forefront of helping HIT vendors and physicians take the next step – and send ALL prescriptions electronically.     

What states are we still watching? 

And then there were 3 - Arkansas, Montana, and Rhode Island

Arkansas, Montana, and Rhode Island are the three states where EPCS still remains unavailable as their state governments sort out the differences in the State Laws versus the DEA rulings.  Arkansas made progress by passing Act 1331 in April of 2013 to clarify that electronic prescribing of controlled substances is permitted.  Furthermore, the Arkansas State Board of Pharmacy had a public hearing scheduled to discuss the changes in February 2014, but it was postponed until March due to poor weather conditions.  Rhode Island also passed a similar bill, SB 647, in June of 2013 which states, “A practitioner may sign and transmit electronic prescriptions for controlled substances.”  However, further clarification is still needed from all three states before EPCS is allowed.  Stay tuned as we will post any updates as soon as we get them!   

Oregon

While Oregon is listed as allowing Schedule II-V substances to be sent electronically on the Surescripts map, Schedule II substances can actually only be legally e-Prescribed in emergency situations.    A bill was introduced on February 3, 2014, that if approved would allow all controlled substances including Schedule II drugs to be electronically sent in non-emergency situations as well.

New York

All eyes are on New York as they are leading the way by being the first state to mandate that all prescriptions be sent electronically.  It was almost a year ago that EPCS became legal in the state of New York.  As of March 27, 2013, amendments to Title 10 NYCRR Part 80 Rules and Regulations on Controlled Substances went into effect, technically allowing providers in New York to electronically prescribe Schedule II-V drugs1.  However, the actual implementation of EPCS has been slower than expected as the state of New York was overdue finalizing its registration process.  Pharmacies and providers are still currently struggling to meet all the requirements. 

It was not until January 23, 2014 that Surescripts was able to turn on EPCS functionality for the State of New York.  Currently, out of 5,579 registered New York pharmacies there are only about 850 listed as being able to receive electronic controlled substance prescriptions on the Surescripts network.  As we mentioned in our post about the Evolution of EPCS, pharmacy software must go through a DEA Certification or third-party audit to verify they comply with the strict regulations put in place by the DEA and through a Surescripts certification.  In addition, pharmacies in New York are also required to submit dispensing data for controlled substances using the American Society for Automation in Pharmacy (ASAP) format Version 4.2 or greater2

It is not only the pharmacies in New York that have to go through extra steps to use EPCS, the prescribers do as well.  The New York State Department of Health, Bureau of Narcotic Enforcement (BNE) recently released registration packets that are required for each prescriber who would like to transmit electronic prescriptions for controlled substances.  All prescribers must register their electronic prescribing software and be able to provide proof of a DEA certification or third party audit verifying the software meets the federal security requirements for transmitting controlled substance prescriptions electronically.  The DEA requires that all prescribers go through strict identity proofing and receive two-factor authentication credentials for EPCS.  Prescribers must attest that they have personally met these federal requirements when registering with the BNE as well. 

With the New York I-STOP Law mandating that ALL prescriptions be electronically sent by March 27, 2015 with limited exceptions, providers only have a little over a year to register and begin using EPCS certified software.

MDToolbox is prepared and ready to help any providers meet this fast approaching deadline.   We are currently offering free EPCS software tokens for a year to any providers that sign up.  Check out our EPCS page and contact us at info@mdtoolbox.com for more information. 

 

  1. https://www.health.ny.gov/regulations/recently_adopted/docs/2013-02-13_electronic_prescribing_dispensing_and_recordkeeping_of_controlled_substances.pdf
  2. https://www.health.ny.gov/professionals/narcotic/electronic_prescribing/

 

The Evolution of EPCS

Posted by on Comments (0)

Electronic prescribing of controlled substances (EPCS) is just starting to gain ground.  The Drug Enforcement Agency (DEA) rule allowing prescribers to electronically write prescriptions for controlled substances actually went into effect over three years ago.  However, its adoption has been slow. 

The need to be able to send controlled substances electronically is definitely there.  Approximately 11% of all prescriptions written are for controlled substances and 90% of prescribers write prescriptions for such drugs1.  If these prescriptions can’t be sent electronically, prescribers must handwrite or print them.  This can be a big interruption and slowdown in a prescriber’s workflow.  In addition, EPCS increases safety and decreases fraud.  So why is it taking so long for EPCS to become a norm? 

The DEA’s Interim Final Rule (IFR) first approved electronic sending and receiving of controlled substances in March 2010, and it went into effect on June 1, 2010.  Though in order to actually use EPCS, prescribers, e-Prescribing software, and pharmacy software must meet strict regulations.  Prescribers are required to go through stringent identity proofing and receive two-factor authentication credentials.  Each time they send a controlled substance, prescribers must use their two-factor authentication.  The two-factor has to be two of the following three items:

1) Something only the prescriber KNOWS, like a password or an answer to a challenge question

2) Something the prescriber IS, biometric data such as a fingerprint or 

3) Something the prescriber HAS like a device or token separate from the computer he is prescribing on.   

E-Prescribing software and pharmacy software must go through a DEA Certification or third-party audit to verify they comply with the regulations.  The IFR requires e-Prescribing software to have a two-factor authentication protocol, have access controls so only prescribers with the proper permissions can send controlled substance prescriptions, and put extra security and auditing measures in place.  Pharmacy software is also required to have access controls and stricter security measures, as well as additional features to be able to receive electronic controlled substance prescription orders.

In addition to the Federal DEA requirements, each state has their own laws and regulations concerning EPCS.  While 47 states have approved EPCS, there is still a small percentage of pharmacies in each of these states that are able to receive electronic prescriptions for controlled substances. 

It is clear that meeting all of these requirements can be challenging and takes ample time and money for all involved.  This has caused the progression to be quite slow.  Here’s how it looks on a year-by-year basis:

2010: DEA IFR goes into effect and states begin aligning their rules with those of the DEA.

2011: Software vendors working to meet requirements.

2012: First e-Prescribing and pharmacy software vendors certified.  Surescripts® reports a “modest number of EPCSs” transmitted in eight states as of May 2012.   

2013: About 14,000 pharmacy stores signed up for EPCS in 44 states, but only about 1,000 prescribers nationwide using EPCS as of Mid-2013.

2014: About 20,000 pharmacy stores signed up for EPCS in 47 states.  However, only 14 e-Prescribing systems certified for EPCS out of over 600 prescribing applications on the Surescripts® network. 2

 

Out of almost 70,000 total pharmacies and more than half a million e-Prescribing prescribers, the numbers of those using EPCS are still small.  However, that’s changing as EPCS growth takes off.

As one of the 14 certified Prescriber EPCS systems, MDToolbox is at the forefront of the EPCS movement.  We see now as the time that EPCS is going to take off.  MDToolbox is offering both standalone EPCS for prescribers and EPCS plug-in modules for EHRs looking for a quick and inexpensive way to get on-board with the movement.  With laws like New York’s I-STOP mandating ALL prescriptions be sent by March 27, 2015, we believe EPCS will see huge growth in 2014. 

What do you think?  We would love to hear from you and get your feedback, comments and questions. Leave a comment below or feel free to contact us at info@mdtoolbox.com.     

 

  1. Rannazzisi JT. A Prescription for Waste: Controlled Substance Abuse in Medicaid. Drug Enforcement Administration (DEA). September 30, 2009. www.justice.gov/dea/pr/speeches-testimony/2012-2009/ct093009.pdf. Accessed January 27,2014.
  2. Surescripts - http://www.surescripts.com/medication-network-services/e-prescribing-of-controlled-substances/regulatory-status-map

Top 5 Mistakes in Writing Quality E-Prescriptions

Posted by on Comments (0)

Electronic prescribing (e-Prescribing) has been praised for increasing patient safety by providing clearer prescriptions and reducing medication errors.  Pharmacists no longer have to worry about interpreting the prescriber’s handwriting.  However, it has been found that even with e-Prescribing, more than 10% of prescriptions still contain an error1.  These errors can be highly dangerous, or even deadly.  Here we list out our top 5 mistakes found in electronic prescriptions (e-prescriptions) and solutions to prevent them.

    1.  Wrong Drug Name or Strength

One of the most dangerous medication errors is prescribing the wrong drug or strength.  E-Prescribing prevents errors that occur from illegible writing, but incorrect medication errors can still occur.  In many e-Prescribing systems, the prescriber selects the drug to prescribe from a lookup.  It is easy to see how a rushed prescriber could make a mis-click and pick the wrong drug or strength.  Additionally, several drugs have similar names.  If prescribers are not careful, they can easily confuse them with each other.  Of all medication errors, the FDA reports that about 10% come from drug name confusion2.  Several drugs have different strengths and some have different dosage routes as well.  For example, Ofloxacin is available in both a 0.3% opthamalic solution and a 0.3% otic solution.  Choosing the wrong route could have serious effects.  Selecting the wrong drug, strength, or route could even be fatal.  This is why it is critical that prescribers double check these fields when selecting a drug to e-prescribe. 

A good way to prevent picking the wrong drug name is to use e-Prescribing software that includes tall man lettering to help in selecting look-alike drug names.  These drug names include both lower and upper case letters in order to draw attention to the differences in their names.  For example, two similarly named insulins are listed as NovoLOG and NovoLIN to differentiate between them.

2.  Unclear Directions

The most important part of a prescription for the patient is the directions.  If the patient does not understand how to take/use the prescription, they will not get the intended results and it could be potentially harmful.  A common mistake in e-prescriptions is to write directions that include abbreviations, are incomplete, or that say something generic like “Take as directed.”

The directions must be written out fully in terms that the patient will understand.  They should not include any abbreviations or anything that the pharmacist would need to interpret or rewrite.   While pharmacists may understand the abbreviations, the reality is the busy pharmacist (or rather pharmacist assistant) will quickly re-write it or a computer program will re-write it for them and the translation is many times incorrect.   These mistakes can be fatal.  For example, the FDA reported a patient died when 20 units of insulin was abbreviated as "20 U," and the "U" was mistaken for a "zero"3.  The patient received an incorrect dose of 200 units as a result.

Prescribers must also not assume the patient will remember the directions they gave them orally – Including the full directions in the electronic message to the pharmacist gives the patient written clear directions they can check if they cannot remember what the prescriber told them.  Directions should always include when, how often, and how to take the medication

It is also important to make sure any numbers written in the directions are safely written.  Decimal points can be easily missed.  For example, 1.0 could be quickly read as 10 or .1 could be read as 1.  Prescribers should never include a decimal point and a trailing zero (X.0mg) but should always include a leading zero before a decimal point (0.Xmg).  It is recommended to try to avoid the use of zeroes by using alternative units of measure – for example use “50 micrograms” instead of “0.05 milligrams.” 

3.  Including Directions in the Wrong Place

Another common mistake in e-prescriptions is including direction information in a note or comment field.  The note field is a helpful field that allows prescribers to add additional free text information that is not part of the prescription.  However, this field should never be used for drug name, directions, the number of days, or any important information.  Many prescribers feel the need to include direction information in the note field because their e-Prescribing software does not allow them to enter custom directions.  It is quite challenging to prescribe medications that require tapering or titrations if the prescriber can only enter pre-structured directions.  The problem is most of the pharmacy software does not show the note information on the main dispensing screen and this makes it easy for the pharmacist to miss it.  This can then cause the pharmacist to include incorrect or incomplete directions.  Prescribers sometimes include conflicting direction information in the pharmacy note box as well.  For example a conflict might look like:

Directions:   3 times a day

Free Text Note:  1 GTT Q4 OD – patient has a coupon 

If the pharmacist fills based on directions, they have no idea how much the patient should take three times a day.  If the pharmacist happens to check the free text note field, they now know how much but have conflicting “how often”.  This causes the pharmacist to have to contact the prescriber for clarification and slows down the entire process of e-Prescribing.  This is why it is critical for prescribers to include the full directions in the directions box and only use the pharmacy note field for additional information.  A proper prescription might look like:

Directions:   1 drop in the right ear every  4 hours daily

Free Text Note:  Patient has a coupon

Using e-Prescribing software that allows prescribers to easily free text any custom directions needed, as well as customize their sig and direction lookups, is a great solution for preventing information being placed in the wrong field.  Using these solutions, as opposed to solutions where prescribers can only select pre-structured directions or have to complete complicated extra steps to have detailed directions, is an ideal way to avoid this information from being unseen or conflicting. 

4.  Incorrect Dosage

Another highly dangerous medication error is prescribing the wrong dosage.  It is easy for a prescriber to make a mistake when converting units of measurement or calculating a dose.  These mistakes can result in doses 10 or 100 times the intended amount.  For example, an infant recently died after receiving an overdose of morphine when a 3.5mg dose was given rather than what should have been a 0.35mg dose.  There have been many other cases where these kinds of mistakes have led to fatalities as well.  This is why it is important for prescribers to check and double check the dose they are prescribing. 

A great solution for prescribers is to use an e-Prescribing system that includes dosing references and a dosing calculator at the point of prescribing.   These calculators help prevent calculation errors and give warnings if the calculated doses are too high.  These are especially useful for pediatrics per weight based dosing.  In some systems, like MDToolbox, it will even convert mg per kg to mL automatically if needed for prescribers.  

5.  Wrong Quantity

Prescribers also make the mistake of including a quantity for either the number of days the prescription is for or the amount to be dispensed that is wrong in e-prescriptions.  Prescribing more or less of a medication than intended can have serious effects.   This is why it is important for prescribers to double check the dispense amount and the number of days it should last.  It is important that these amounts do not contradict each other or the directions, otherwise the pharmacist will not know which is the correct amount.

An example of a contradicting prescription:    

Directions:  Take 1 Tablet Daily for 5 days by Mouth

Days Supply:   5

Dispense #:  20

How many should the pharmacist dispense?   Does the patient need to take 20 pills over the next five days?   Or, do they only need to take one daily for five days and thus, only five tablets should be dispensed?  A patient could have serious adverse effects if they take the wrong amount of a prescription.  To ensure safe prescribing, a quality prescription should look like:

Directions:  Take 1 Tablet Daily by Mouth

Days Supply:   5

Dispense #:  5

To further prevent quantity errors, prescribers can use software (like MDToolbox) that helps them with auto calculating these amounts based on the directions and either the selected number of days or dispense number.

In addition to avoiding these mistakes, there are further steps prescribers should take to prevent medication errors.  They should always take the time to double check the complete prescription information before hitting e-Send.  Taking this small extra step can help catch a lot of unnecessary errors.  Prescribers should also make sure that the patient is clear about which prescription they are prescribing for them and the proper way to take/use it.  This way the patient can double check they are receiving the right prescription from the pharmacy and be able to use it as intended.  Prescribers should also use e-Prescribing software that allows them to print patient leaflets, as well as a medication summary that lists the prescriptions to give to the patient.  Medication summaries are a good way to remind the patient which medications were prescribed, how often to take them and which pharmacy they were e-Sent to. 

E-Prescribing continues to improve prescription safety.   We can take patient safety to the next level and minimize medication errors even further with a combination of prescribers following a few simple guidelines, double checking their prescriptions and using patient safety focused e-Prescribing software.   

If you have comments or suggestions for our blog or would like to learn more about MDToolbox’s e-Prescribing solutions we would love to hear from you!  Please leave a comment below, use our contact form or email us any time at info@mdtoolbox.com

 

  1. Nanji KC, et al "Errors associated with outpatient computerized prescribing systems" J Am Med Inform Assoc 2011; DOI:10.1136/amiajnl-2011-000205.
  2. Rados C. “Drug name confusion: preventing medication errors.” FDA Consumer Magazine. 2005;39. www.fda.gov/fdac.
  3. "Strategies to Reduce Medication Errors: Working to Improve Medication Safety." U.S. Food and Drug Administration, 12 Apr. 2013. Web. 09 Jan. 2014.

Alerts No Longer Alerting

Posted by on Comments (0)

One of the biggest draws of e-Prescribing is increasing safety by providing alerts for adverse reactions.  E-Prescribing systems can show warnings to prescribers for drug-drug, drug-allergy, drug-condition, and many other potential interactions.  However, these alerts actually become a problem if they are shown too often.  Prescribers start to have what is known as Alert Fatigue and completely ignore some or all of these warnings.  If messages are constantly popping up, a prescriber is likely to pay less attention to them and simply override them to continue with their workflow.  Studies have even shown as much as 95 percent of drug interaction alerts and 77 percent of drug allergy alerts are disregarded by doctors. 

This would not be such a huge issue if prescribers were only overriding low priority alerts.  However, they are overriding high priority alerts as well.  The problem comes from too many low priority and irrelevant alerts being shown.  Imagine a doctor first receiving a low priority alert, then an alert irrelevant to the patient, then another lower priority alert, and so on.  Doctors become so overwhelmed with alerts that they simply override all of them without taking notice of what they are, including those with the potential to prevent serious harm to patients.  A recent study published in the Journal of the American Medical Informatics Association looked at the appropriateness of overridden alerts.  Appropriate was defined as having the potential to prevent serious harm.  The study found that 53% of all overridden alerts were appropriate1

 

Reducing Alert Fatigue

It seems like a simple concept: To reduce alert fatigue, the number of alerts needs to be minimized. With so much alert information available, the challenge comes from deciding which alerts should be shown and which are less important.  E-Prescribing vendors are also faced with solving how to display the important alerts in a manner that doesn’t diminish work-flow. 

Drug-drug and drug-allergy interaction checking is a criterion in both Meaningful Use Stage 1 and Stage 2.  The 2014 Meaningful Use HIT Certification Program, approved by the Office of the National Coordinator for Health Information Technology (ONC), defines that drug-drug and drug-allergy alerts must both be automatically shown at the point of prescribing.  The drug-drug alerts shown must also be adjustable by severity level2.   

This means that certified products should, at a minimum, be including the ability to minimalize minor drug-drug interaction alerts.   This, however, does not cover severity level per drug-condition or drug-allergy alerts.  A minor intolerance allergy alert should be treated different than a major interaction that can cause serious harm or even death. 

The ONC has also created a list of the most critical drug-drug interactions (separate from the Meaningful Use program).  It has recommended that this list of 15 interactions be included in all prescribing systems and always generate an alert that cannot be turned off.  Some have suggested that these alerts should also require more to override them then the standard alerts, such as a required written reason.  It was also suggested that including these 15 alerts be a criterion for Meaningful Use of drug-drug interaction alerting.  However, this list is said to only be responsible for less than 1 percent of drug interaction alerts in some systems.  What about the rest of the alerts? 

 

Taking it a step further - Eliminating Alert Fatigue

In order to maximize patient safety and prescriber workflow, e-Prescribing systems need to go above and beyond the Meaningful Use Criteria.  There are 3 main points that need to be addressed to work towards the ultimate goal of eliminating alert fatigue:

 

      1. Selecting the Important Alerts

The importance of alert types varies from specialty to specialty and even from doctor to doctor.  This is why it is important for e-Prescribing vendors to have the ability to allow each prescriber to set their own customizable alert levels.  Each prescriber should be able to select for each alert type (not just drug-drug) whether they want to see all of the available alerts, only the highest alerts, or somewhere in between in order to maximize the effectiveness of the alerts. 

 

       2.  Displaying Alerts Without Causing “Fatigue”  

It is important to categorize all alerts by their severity level and display this information in a clear and easy to understand format.  If a prescriber has selected to see all alerts, it is still significant for them to know which are the highest alerts.  Color-coding alerts so that for example, red is the highest, is a good way to make each alert level clear to the user.  Alert fatigue can also be reduced by including all alerts for a given prescribing event together.  Instead of having several individual alerts popup one after another, all alerts should be displayed in one window with the highest level alert displayed at the top.   Review, overriding, or re-evaluation should never involve more than one or two clicks to continue with prescribing workflow.

 

3.  Creating Smarter Alerts 

A lot of e-Prescribing systems categorize each alert by level of risk per one drug interacting with another drug, but what about interaction concerns per age, weight, or condition that increase the risk?  At MDToolbox, we have taken it a step further and allow prescribers to create decision support interventions at the point of prescribing that can take into account other factors (like age, weight) when determining alert display.  We also include optional dosing references, alerts and calculators to further aid in “smart alerts”. 

 

Instead of being viewed as a hindrance in the prescribing workflow, alerts should be viewed as an important safety aid.  We hope that by reducing alert fatigue, the true effectiveness of prescribing medications with an alert system will be realized. 

 

 

  1. Nanji KC, Slight SP, Seger DL, et al. Overrides of medication-related clinical decision support alerts in outpatientsJ Am Med Inform Assoc Published Online First: 28 October 2013. doi:10.1136/amiajnl-2013-001813
  2. Office of the National Coordinator for Health Information Technology (ONC) - Test Procedure for §170.314 (a)(2) Drug-drug, drug-allergy interaction checks:   14  December, 2012.  http://www.healthit.gov/sites/default/files/170.314a2drug_interaction_checks_2014_tp_approvedv1.2.pdf